why choose us

First received: July 19, 2022

Clinical Trial: Humoral and Cellular ?mmune Response to SARS-CoV-2 mRNA BNT162b2 Vaccine in Children With Chronic Kidney Diseases

Study Status: Completed

Recruit Status: Completed

Condition: Chronic Kidney Disease 5D
Chronic Kidney Disease 5T

Study Type: Interventional


Official Title: Humoral and Cellular ?mmune Response to SARS-CoV-2 mRNA BNT162b2 Vaccine in Pediatric Kidney Transplant Recipients Compared to Dialysis Patients and Healthy Children

Brief Summary: Coronavirus 2019 (COVID-19) infection is associated with higher morbidity and mortality in adult patients on dialysis, and kidney transplant recipients (KTRs). Although children had lower morbidity and mortality, KTRs are more vulnerable than healthy children.It has already known that the general immune responses to vaccines, which are currently in practice (attenuated, conjugated, or recombinant) were lower than healthy controls in children and adolescents on dialysis and with a kidney transplantation. Uremic…

Read more